During the past decade, Ospedale S. Vincenzo; Oncologia Medica conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ospedale S. Vincenzo; Oncologia Medica" are "Breast Neoplasms" (1 trials), "Malignant Melanoma" (1 trials) and "Triple-Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Ospedale S. Vincenzo; Oncologia Medica" in a lesser frequency.

Most popular intervention types in "Ospedale S. Vincenzo; Oncologia Medica" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (2 trials), "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials), "Atezolizumab Placebo" (1 trials), "Docetaxel" (1 trials) and "Nab-paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale S. Vincenzo; Oncologia Medica" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale S. Vincenzo; Oncologia Medica". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Ospedale S. Vincenzo; Oncologia Medica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale S. Vincenzo; Oncologia Medica, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".